Literature DB >> 16034212

Intermedilysin is essential for the invasion of hepatoma HepG2 cells by Streptococcus intermedius.

Akiko Sukeno1, Hideaki Nagamune, Robert A Whiley, Syed I Jafar, Joseph Aduse-Opoku, Kazuto Ohkura, Takuya Maeda, Katsuhiko Hirota, Yoichiro Miyake, Hiroki Kourai.   

Abstract

Streptococcus intermedius causes endogenous infections leading to abscesses. This species produces intermedilysin (ILY), a human-specific cytolysin. Because of the significant correlation between higher ILY production levels by S. intermedius and deep-seated abscesses, we constructed ily knockout mutant UNS38 B3 and complementation strain UNS38 B3R1 in order to investigate the role of ILY in deep-seated infections. Strain UNS38 reduced the viability of human liver cell line HepG2 at infection but not of rat liver cell line BRL3A. Isogenic mutant strain UNS38 B3 was not cytotoxic in either cell line. Quantification of S. intermedius revealed that in infected HepG2 cells UNS38 but not UNS38 B3 increased intracellularly concomitantly with increasing cell damage. This difference between UNS38 and UNS38 B3 was not observed with UNS38 B3R1. Invasion and proliferation in BRL3A cells was not observed. Masking UNS38 or UNS38 B3R1 with ILY antibody drastically decreased adherence and invasion of HepG2. Moreover, coating strain UNS38 B3 with ILY partially restored adherence to HepG2 but without subsequent bacterial growth. At 1 day post-infection, many intact UNS38 were detected in the damaged phagosomes of HepG2 with bacterial proliferation observed in the cytoplasm of dead HepG2 after an additional 2 day incubation. These results indicate that surface-bound ILY on S. intermedius is an important factor for invasion of human cells by this bacterium and that secretion of ILY within host cells is essential for subsequent host cell death. These data strongly implicate ILY as an important factor in the pathogenesis of abscesses in vivo by this streptococcus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034212     DOI: 10.1111/j.1348-0421.2005.tb03647.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  19 in total

1.  Identification and characterization of a novel secreted glycosidase with multiple glycosidase activities in Streptococcus intermedius.

Authors:  Hidenori Imaki; Toshifumi Tomoyasu; Naoki Yamamoto; Chiharu Taue; Sachiko Masuda; Ayuko Takao; Nobuko Maeda; Atsushi Tabata; Robert A Whiley; Hideaki Nagamune
Journal:  J Bacteriol       Date:  2014-05-23       Impact factor: 3.490

2.  Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.

Authors:  Toshifumi Tomoyasu; Atsushi Tabata; Riki Hiroshima; Hidenori Imaki; Sachiko Masuda; Robert A Whiley; Joseph Aduse-Opoku; Ken Kikuchi; Keiichi Hiramatsu; Hideaki Nagamune
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

3.  Role of Streptococcus intermedius DnaK chaperone system in stress tolerance and pathogenicity.

Authors:  Toshifumi Tomoyasu; Atsushi Tabata; Hidenori Imaki; Keigo Tsuruno; Aya Miyazaki; Kenji Sonomoto; Robert Alan Whiley; Hideaki Nagamune
Journal:  Cell Stress Chaperones       Date:  2011-08-06       Impact factor: 3.667

4.  LacR mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence.

Authors:  Toshifumi Tomoyasu; Hidenori Imaki; Sachiko Masuda; Ayumi Okamoto; Hyejin Kim; Richard D Waite; Robert A Whiley; Ken Kikuchi; Keiichi Hiramatsu; Atsushi Tabata; Hideaki Nagamune
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

5.  Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.

Authors:  Toshifumi Tomoyasu; Takahiro Yamasaki; Shinya Chiba; Shingo Kusaka; Atsushi Tabata; Robert A Whiley; Hideaki Nagamune
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

Review 6.  The role of Streptococcus intermedius in brain abscess.

Authors:  A K Mishra; P-E Fournier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-28       Impact factor: 3.267

7.  The pore-forming toxin listeriolysin O mediates a novel entry pathway of L. monocytogenes into human hepatocytes.

Authors:  Stephen Vadia; Eusondia Arnett; Anne-Cécile Haghighat; Elisabeth M Wilson-Kubalek; Rodney K Tweten; Stephanie Seveau
Journal:  PLoS Pathog       Date:  2011-11-03       Impact factor: 6.823

8.  Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.

Authors:  Timothy R Hughes; Kirsty S Ross; Graeme J M Cowan; Baalasubramanian Sivasankar; Claire L Harris; Timothy J Mitchell; B Paul Morgan
Journal:  Mol Immunol       Date:  2009-02-06       Impact factor: 4.407

9.  Pangenome analysis and virulence profiling of Streptococcus intermedius.

Authors:  Dhiraj Sinha; Xifeng Sun; Pierre-Edouard Fournier; Mudra Khare; Michel Drancourt; Didier Raoult
Journal:  BMC Genomics       Date:  2021-07-09       Impact factor: 3.969

10.  Genome Sequence of the Human Abscess Isolate Streptococcus intermedius BA1.

Authors:  Paul J Planet; Ryan Rampersaud; Saul R Hymes; Susan Whittier; Phyllis A Della-Latta; Apurva Narechania; Sean C Daugherty; Ivette Santana-Cruz; Robert Desalle; Jacques Ravel; Adam J Ratner
Journal:  Genome Announc       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.